Long-term [tmco]
Hormone Therapy [topp]
Perimenopausal [tmco]
postmenopausal [tmco]
Women [popg]
Background [cnce]
Hormone Therapy [topp]
controlling [ftcn]
menopausal symptoms [sosy]
Management [ocac]
Prevention [topp]
Cardiovascular disease [dsyn]
Osteoporosis [dsyn]
dementia [mobd]
Old [tmco]
Women [popg]
This [euka]
Update [tmco]
Version [ftcn]
Review [inpr]
First [qnco]
Published [ocac]
objectives [inpr]
To [qlco]
Assess [acty]
effects [qlco]
Long-term [tmco]
Hormone Therapy [topp]
Mortality [qnco]
CARDIOVASCULAR [bdsy]
Outcome [ftcn]
Cancer [neop]
Gall Bladder Disease [dsyn]
Fractures [inpo]
Cognition [menp]
Quality [qlco]
Life [idcn]
Perimenopausal [tmco]
postmenopausal [tmco]
Women [popg]
Hormone Therapy [topp]
Cessation [acty]
Hormone Therapy [topp]
search [inpr]
Methods [inpr]
Searched [acty]
Following [tmco]
Databases [inpr]
Menstrual disorders [patf]
Sub-Fertility [dsyn]
Group [idcn]
Trial [resa]
Central [spco]
Controlled [ftcn]
Trial [resa]
MEDLINE [inpr]
Selection Criteria [qlco]
included [ftcn]
Studies, Double-Blind [resa]
Hormone Therapy [topp]
placebo [topp]
Taken [cnce]
One [qnco]
Perimenopausal [tmco]
postmenopausal [tmco]
Women [popg]
Hormone Therapy [topp]
included [ftcn]
Oestrogens [horm, phsu, strd]
Progestogens [horm, phsu, strd]
Oral [spco]
Transdermal [ftcn]
subcutaneous [spco]
Intranasal [spco]
routes [spco]
Data Collection [resa]
Analysis [lbpr]
Two [qnco]
Authors [prog]
Assessed [acty]
Study [mnob]
Quality [qlco]
Extracted [topp]
Data [idcn]
Calculated [ftcn]
Risk Ratios [qnco]
Dichotomous [qlco]
Data [idcn]
Mean [qnco]
Continuous [idcn]
Data [idcn]
Confidence Intervals [qnco]
findings [ftcn]
statistically significant [qnco]
Calculated [ftcn]
absolute risk [qnco]
Intervention Group [popg]
Overall [inpr]
Risk [qlco]
Event [evnt]
Women [popg]
Take [hlca]
Hormone Therapy [topp]
Main [qlco]
Result [ftcn]
twenty [orch, phsu]
Three [qnco]
studies [lbpr]
Involving [ftcn]
Women [popg]
included [ftcn]
Percent [qnco]
Data [idcn]
Derived [qlco]
Two [qnco]
studies [lbpr]
WHI [inpr]
participants [popg]
postmenopausal [tmco]
American [popg]
Women [popg]
Degree [qlco]
co-morbidity [idcn]
Mean [qnco]
Participant [popg]
Age [orga]
studies [lbpr]
Over [spco]
studies [lbpr]
Focused [spco]
Perimenopausal [tmco]
Women [popg]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Fit [sosy]
Disease [dsyn]
Combined [qlco]
Continuous [idcn]
Hormone Therapy [topp]
Increased [qnco]
Risk [qlco]
coronary [bpoc]
Event [evnt]
One [qnco]
absolute risk [qnco]
Venous embolism [acab]
One [qnco]
absolute risk [qnco]
Stroke [dsyn]
Three [qnco]
absolute risk [qnco]
Breast Cancer [neop]
absolute risk [qnco]
Gall Bladder Disease [dsyn]
absolute risk [qnco]
Death [orgf]
Lung Cancer [neop]
Additional [ftcn]
Follow-up [fndg]
absolute risk [qnco]
Estrogen hormone therapy [topp]
Only [qnco]
Increased [qnco]
Risk [qlco]
Venous embolism [acab]
One [qnco]
Two [qnco]
absolute risk [qnco]
absolute risk [qnco]
Stroke [dsyn]
absolute risk [qnco]
Gall Bladder Disease [dsyn]
Seven [qnco]
absolute risk [qnco]
Not [ftcn]
Increase [ftcn]
Risk [qlco]
Breast Cancer [neop]
Women [popg]
Aged [orga]
Health [idcn]
Take [hlca]
Continuous [idcn]
Combined therapy [topp]
Hormone [horm]
statistically significant [qnco]
Increase [ftcn]
Incidence [qnco]
dementia [mobd]
absolute risk [qnco]
Women [popg]
Cardiovascular disease [dsyn]
Long-term [tmco]
Combined therapy [topp]
Continuous [idcn]
Hormone [horm]
Increased [qnco]
Risk [qlco]
Venous embolism [acab]
One [qnco]
absolute risk [qnco]
Women [popg]
Take [hlca]
Hormone Therapy [topp]
Decreased [qnco]
Incidence [qnco]
Fractures [inpo]
Long-term [tmco]
Combined therapy [topp]
Hormone [horm]
absolute risk [qnco]
Estrogen hormone therapy [topp]
Only [qnco]
absolute risk [qnco]
Risk [qlco]
Fracture [inpo]
Only [qnco]
Outcome [ftcn]
Strong [qlco]
Evidence [ftcn]
Clinical [qlco]
Benefit [qnco]
Hormone Therapy [topp]
Strong [qlco]
Evidence [ftcn]
Hormone Therapy [topp]
Meaning [idcn]
IMPACT [gngm]
Incidence [qnco]
Colorectal Cancer [neop]
One [qnco]
Trial [resa]
subgroups [virs]
Health [idcn]
Old [tmco]
Women [popg]
Take [hlca]
Combined therapy [topp]
Continuous [idcn]
Hormone [horm]
Take [hlca]
Estrogen hormone therapy [topp]
Only [qnco]
Similar [qlco]
size [spco]
placebo [topp]
Group [idcn]
Only [qnco]
Increased [qnco]
Risk [qlco]
Reported [inpr]
Venous embolism [acab]
Women [popg]
Take [hlca]
Combined therapy [topp]
Continuous [idcn]
Hormone [horm]
absolute risk [qnco]
low [qlco]
Risk [qlco]
Excluded [idcn]
Study [mnob]
Not [ftcn]
Design [acty]
To [qlco]
Power [hcpp]
detect [fndg]
Group [idcn]
Women [popg]
Menopause [phsf]
Authors [prog]
Conclusions [idcn]
Hormone Therapy [topp]
Not [ftcn]
Indicated [fndg]
Primary [qlco]
Secondary Prevention [topp]
Cardiovascular disease [dsyn]
dementia [mobd]
PREVENT [phsu]
Deterioration [phpr]
cognitive function [menp]
postmenopausal [tmco]
Women [popg]
Hormone Therapy [topp]
considered [idcn]
effective [qlco]
Prevention [topp]
Osteoporosis, Post-Menopausal [dsyn]
Recommended [idcn]
Option [ftcn]
Only [qnco]
Women [popg]
Risk [qlco]
Non [ftcn]
estrogen therapies [topp]
Insufficient [qlco]
Data [idcn]
Assess [acty]
Risk [qlco]
Long-term [tmco]
Hormone Therapy [topp]
Perimenopausal [tmco]
Women [popg]
postmenopausal [tmco]
Women [popg]
Young [tmco]
Age [orga]
